FPS
ABBV icon

Fieldpoint Private Securities’s AbbVie ABBV Stock Holding History

Fieldpoint Private Securities’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$4.44M Sell
28,999
-7,154
-20% -$1.09M 1.29% 11
2022
Q1 		$5.86M Buy
36,153
+972
+3% +$141K 1.21% 9
2021
Q4 		$4.76M Buy
35,181
+381
+1% +$45K 0.93% 16
2021
Q3 		$3.75M Buy
34,800
+92
+0.3% +$10.5K 0.83% 22
2021
Q2 		$3.98M Buy
34,708
+1,420
+4% +$160K 0.87% 22
2021
Q1 		$3.6M Sell
33,288
-2,487
-7% -$266K 0.84% 23
2020
Q4 		$3.83M Buy
35,775
+8,951
+33% +$860K 0.87% 25
2020
Q3 		$2.35M Buy
26,824
+480
+2% +$45.2K 0.69% 35
2020
Q2 		$2.59M Sell
26,344
-11,698
-31% -$1.03M 0.87% 31
2020
Q1 		$2.9M Buy
38,042
+780
+2% +$66.4K 1.12% 21
2019
Q4 		$3.3M Buy
37,262
+18,639
+100% +$1.55M 0.97% 23
2019
Q3 		$1.41M Sell
18,623
-156
-0.8% -$10.7K 0.51% 55
2019
Q2 		$1.37M Buy
18,779
+1,794
+11% +$141K 0.43% 63
2019
Q1 		$1.37M Hold
16,985
– – 0.57% 51
2018
Q4 		$1.57M Sell
16,985
-487
-3% -$42.8K 0.69% 41
2018
Q3 		$1.65M Hold
17,472
– – 0.63% 44
2018
Q2 		$1.62M Hold
17,472
– – 0.62% 46
2018
Q1 		$1.65M Sell
17,472
-4,670
-21% -$513K 0.75% 35
2017
Q4 		$2.14M Sell
22,142
-1,195
-5% -$113K 1.13% 22
2017
Q3 		$2.07M Buy
23,337
+1,157
+5% +$88.1K 0.89% 25
2017
Q2 		$1.61M Sell
22,180
-750
-3% -$50.4K 1.1% 15
2017
Q1 		$1.49M Buy
+22,930
New +$1.44M 1.16% 26

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fieldpoint Private Securities's ABBV Position: Q2 2022 in Review

Fieldpoint Private Securities reduced its AbbVie (ABBV) stake by 20% in Q2 2022, selling an estimated $1.09M and leaving 28,999 shares worth $4.44M. The position accounts for 1.29% of the portfolio, ranked #11.

Fieldpoint Private Securities first reported a position in ABBV in Q1 2017 and has held it in 22 quarters since. The position peaked at $5.86M in Q1 2022. 3,005 funds tracked by Wall St. Rank hold ABBV as of Q2 2022.

  • Fieldpoint Private Securities held 28,999 shares of AbbVie worth $4.44M as of Q2 2022.
  • Fieldpoint Private Securities sold 7,154 AbbVie shares in Q2 2022, an estimated $1.09M.
  • AbbVie made up 1.29% of Fieldpoint Private Securities's portfolio in Q2 2022, its #11 holding.
  • Fieldpoint Private Securities first reported a position in AbbVie in Q1 2017 and has held it in 22 quarters since.
  • Fieldpoint Private Securities's AbbVie position peaked at $5.86M in Q1 2022.
  • 3,005 funds tracked by Wall St. Rank held AbbVie as of Q2 2022.

Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.